---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289233346.md"
description: "West Pharmaceutical Servs shares are trading higher after Barclays upgraded the stock from Equal-Weight to Overweight rating and raised its price target from $310 to $400."
datetime: "2026-06-09T19:21:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289233346.md)
  - [en](https://longbridge.com/en/news/289233346.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289233346.md)
---

# 

West Pharmaceutical Servs shares are trading higher after Barclays upgraded the stock from Equal-Weight to Overweight rating and raised its price target from $310 to $400.

### Related Stocks

- [WST.US](https://longbridge.com/en/quote/WST.US.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)

## Related News & Research

- [West Pharmaceutical Services' (WST) "Overweight" Rating Reiterated at Stephens](https://longbridge.com/en/news/288428697.md)
- [A Look At West Pharmaceutical Services (WST) Valuation After Recent Share Price Consolidation](https://longbridge.com/en/news/288933254.md)
- [West Appoints Michel Lagarde to be President and Chief Executive Officer | WST Stock News](https://longbridge.com/en/news/288323873.md)
- [West Pharma names former Thermo Fisher executive Lagarde as CEO](https://longbridge.com/en/news/288329895.md)
- [West Pharma says operations recovering after cyberattack](https://longbridge.com/en/news/286600239.md)